Crossmark

Endogenous retroviruses: unveiling new targets for cancer immunotherapy

Crossref DOI link: https://doi.org/10.1038/s41576-024-00784-0

Published Online: 2024-10-03

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suo, Shengbao https://orcid.org/0009-0008-8943-2956
License Information

Text and Data Mining valid from 2024-10-03

Version of Record valid from 2024-10-03
More Information

Article History

First Online: 3 October 2024

Competing interests

: The author declares no competing interests.